Get started
ADVANCED MICRO DEVICES INC CEDEARS (EACH 10REP 1 COM USD0.01) USDADVANCED MICRO DEVICES INC CEDEARS (EACH 10REP 1 COM USD0.01) USDADVANCED MICRO DEVICES INC CEDEARS (EACH 10REP 1 COM USD0.01) USD

ADVANCED MICRO DEVICES INC CEDEARS (EACH 10REP 1 COM USD0.01) USD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

AMDD trade ideas

AMD Stock Analysis: Testing Resistance and Potential MovementsAMD stock appears to have lacked strong upward momentum as it couldn't close above the red signal on the daily chart. If the daily chart closes below the red signal again, the initial reaction area could be the Kaufman Moving Average at 167.15. On daily closings above the red signal, it may experience some bounce from the middle band of the channel; however, a daily close above the channel might indicate a potential upward momentum. WARNING: THIS ANALYSIS IS NOT INVESTMENT ADVICE. CONSIDER YOUR RISK TOLERANCE AND FINANCIAL SITUATION BEFORE MAKING DECISIONS. PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS; THIS IS PURELY AN OPINION. INVEST WISELY AND CONDUCT THOROUGH RESEARCH.
NASDAQ:AMD
by Can_EasyMoney_TR
Wormhole Set to Use AMD Chips for Scaling 'Light Client' ProofsInteroperability platform Wormhole will leverage Advanced Micro Devices' ( NASDAQ:AMD ) enterprise-grade FPGA hardware accelerator chips for scaling cross-chain communication. The project will make use of AMD’s Alveo U55C and U250 adaptable accelerator cards to enhance capacity for secure cross-chain messages using zero-knowledge proofs (ZKPs). As a bridge solution connecting over 30 blockchains, Wormhole has embraced the integration of zero-knowledge proofs into the platform. It is developing “light client” implementations for secure transfers across various chains, using ZKPs. The goal is to create secure “corridors” between blockchains for messaging. Moreover, this necessitates substantial computing power for the generation and verification of proofs across networks. That’s where the Advanced Micro Devices ( NASDAQ:AMD ) chips come into the picture. These FPGA chips are widely used for compute-heavy tasks like training machine learning models. Wormhole is optimizing its platform for AMD chips. "Advanced Micro Devices ( NASDAQ:AMD ) plays a critical role in this effort by providing enterprise-grade FPGA and GPU hardware and lending deep hardware expertise to Wormhole ZK engineers to ensure efficiency and speed,” said Dan Reecer, co-founder and chief operating officer at Wormhole Foundation. Advanced Micro Devices ( NASDAQ:AMD ) contribution to the project supersedes hardware provision — it will also share its expertise in hardware acceleration to improve the scalability of applications developed within the Wormhole ecosystem. Zero Knowledge-Based Light Clients In the coming months, organizations contributing to Wormhole will start rolling out mainnet deployments of various zero-knowledge (ZK) light clients. Just last week, Wormhole revealed a collaboration with Succinct Labs, to enhance the development and performance of an Ethereum-based ZK light client. Wormhole’s plan is to create secure communication channels across major blockchains, including Ethereum, Near, Solana, Aptos, Sui, and Cosmos. Scaling concerning proof generation and verification in the light clients will be facilitated through Advanced Micro Devices ( NASDAQ:AMD ). Wormhole’s core contributors emphasize the critical importance of its product security. This stance stems from an incident in February 2022, when a security breach facilitated by a signature verification flaw in the Wormhole network on Solana led to the theft of over $320 million in $ETH. Fortunately, the compromised funds were later recovered. According to the contributors, ZK-based light clients will significantly contribute to improving the project’s security and decentralization.
NASDAQ:AMD
by DEXWireNews
TSI Market Timer V4.0TSI Market Timer Version 4.0 This indicator is probably one of the best, if not the best indicator out there on the market today. A bold claim. I say that because this indicator has been 10 years, at least, in the making. I started using TradingView in 2015 when it was $5 to use. It was wonderful. And you could make your own indicators. I would copy and reuse many of the indicators I found. This tinkering with indicators and theories would last until the present day. I find the market is interesting and there are many new things to learn and so you can make nearly endless indicators. About This Indicator: The TSI Market Timer Version 4.0. First, a little theory. I have found that, in practice, if you take any price or indicator (like Acc/Dist) or VIX or even ratio charts like (HIGN/LOWN , a new highs new lows ratio) and you apply the True Strength Indicator (TSI)... that you can plot everything on one charting window. I have extensively tested this out over the years. There is a concept in math and statistics called standardization. One common way this is used in trading is the z-score. You may have heard of the Altman Z-score. In this indicator, I have combined several useful signals into one indicator. These are plotted on an auto-scaled plot with a zero line. Here is an explanation of the lines and their colors. - White lines : These are TSI price lines using two variations in the calculations. One is done using a SMA or simple moving average, the other is done using an exponential moving average. I have even used the weighted moving average. However, I find the SMA/EMA to be the most "error free" version. If the EMA white line (price) is above the SMA white line, then it is bullish because the most recent price changes are given more weighting with the EMA version. Thus, if EMA white line > SMA white line then it will fill green and if it is less than the SMA version, it will fill with red color. - Lime Green fill : The lime green color on the EMA/SMA white line combo means a new high was touched. This is very useful if you are a William O'Neal Swing Trader as I am. Dr. Wish speaks of the Green Line Breaks which represent new highs and their importance. See www.wishingwealthblog.com - Orange/Gold Line : The Orange Line is the TSI calculation of the DXY (or US Dollar Index). This is something that I noticed that no one else talks about. The US Dollar Index used on the TSI chart is really useful since it moves in direct opposition to the price of many indices. My theory on this is due to the fact that the US Dollar is the "other side of the trade". Thus, if you buy several billion dollars worth of a stock, the US Dollar Index goes down and when you sell the shares back, the US Dollar Index goes back up. Thus, it is tied into borrowing, leverage, borrowing costs, interest rates and similar things. It has a similar relationship to stocks as oil does to airlines. When USOIL is up, AAL or DAL stocks are often down. The leveraging of stock purchases explains why the stock market and the US Dollar work in contrarian directions. I don't know why others have not seen this. It is probably due to the fact that the DXY is a big number and the changes are small and thus it has scaling issues with other forms of analysis. In other words, if you try to evaluate it in other ways, it does not scale on the charting and thus, traders/analysts would dismiss it. Purple Lines : Comparison Indexes Dark Purple Line: TSI Comparison line. Default is VIX line. The Vix Index with the TSI calculation applied. Light purple/ lavendar line: This is an index such as the QQQ, which is used as the default. Both of the purple lines are customizable. Centerline: Accumulation-Distribution (mini): Lastly, we have the centerline which is a smaller version of the light blue line; the Accumulation/Distribution Line. In this case, I wanted to show it as a kind of "money flow". This is a mini-version of the AD line. You can adjust the size using the zoom % on the indicator settings tab. The default is zoomed out 10%. In addition, you can toggle the red/green fills of the stock/DXY lines and the stock/index lines. Cheers!
NASDAQ:AMDLong
by SpreadEagle71
1
$AMD for fun & practice on earningsI do dowsing and read energy in stocks. I really don't have any positive energy in this thing, so decided to give earnings a whirl with a more in depth reading. First thing is the number 46 comes up twice along with 40 and 47. It seems the primary target is 146, however, there's some "magnetism" I guess you'd call it, back to that $120 zone. My last AMD idea that was a total bomb had highlighted into the $125 area, so the fact it's coming again is usually to be respected, it's just a timing issue. One new idea I came up with that did work on TSLA, but isn't tested a whole bunch yet, is to ask for a date in the past that correlates with the next target zone for AMD. So I just did it and get the date of Nov. 15th (last year). As I check my chart for the prices on that date, I see I've actually already asked this question and have a rectangle on the price levels of Nov. 20th. The prices of these 2 dates do overlap, and highlight this $120 area. When I ask what's the low I get 121. So, if you wanted to own AMD shares, I'd definitely consider selling the puts down there and hope I get assigned. Or, just buy it. The price range of the dates is from $116.87 - 121.93. I also asked for a big date to pay attn to and get July 26th. For a closer in date I get 4/12. We'll see!
NASDAQ:AMDShort
by JenRz
AMD - Our short SMASHED! Buyers in fact needed liquidity builtWe predicted this liquidity build by the buyers using our controlled selling orange channel. This morning off of strong selling volume, we gapped down towards the bottom of this channel and are now looking to see how takes control. Can buyers utilize green contination to break us out of orange selling? OR will we see purple tapered controlled buying being utilized by sellers to build more liquidity to then sell off further. Stay tuned! Happy Trading :)
NASDAQ:AMD
by ReigningTrades
2
AMD Update: Still waiting for the retraceWe're still waiting for wave ii to really kick off. Notice we haven't made a new high though? MACD seems reset too and ready for another drop soon. This would mirror AAPL in regard to a move lower in price. AMD is also on neg div on the micros and 1HR chart which supports the count. So far structure carved out what appears to be the a-b waves, and it points to the target box I have drawn. I feel the $120's is our most likely spot for this retrace to end. Until we have more downside action though, I can't refine our target more. When we get more action, I will update. As of now I plan on buying 25-50 shares once we get towards the bottom of this wave ii. Don't forget, beginning February 23rd (this Friday), I will be dramatically changing my posting schedule here on trading view. My last regular post / update will be on that day.
NASDAQ:AMD
by TSuth
1
(MGX)Metagenomi, Inc.: A Genetic Medicine Powerhouse on the RiseNASDAQ:MGX here's an analysis of Metagenomi, Inc.: Chart Data is limited.. Financial Performance: Market Cap: $456.337 million Previous Close: $12.25 52 Week Range: $9.74 - $12.74 Volume: 392,654 Avg. Volume: 1,187,350 Recent News: Introduction: In the dynamic realm of genetic medicine, where breakthroughs hold the promise of revolutionizing healthcare, one company stands out for its pioneering efforts and recent market buzz – Metagenomi, Inc. With a low share price and a scorching-hot market for gene research, investors are eyeing Metagenomi with keen interest. Let's delve into the company's profile, recent developments, and the compelling reasons why it might just be the next big investment opportunity. Company Overview: Metagenomi, Inc., headquartered in Emeryville, California, emerges as a leading player in the gene editing biotechnology sphere. Established in 2016, Metagenomi is dedicated to developing therapeutics using its proprietary metagenomics-derived genome editing toolbox. This arsenal comprises programmable nucleases, base editors, and RNA/DNA-mediated integration systems, positioning the company at the forefront of genetic medicine innovation. Recent IPO and Insider Trading: A recent initial public offering (IPO) catapulted Metagenomi into the spotlight, with 6,250,000 shares of common stock issued at a public offering price of $15.00 per share. Additionally, insider trading activity has surged, with Novo Holdings A/S, a notable insider, acquiring a significant stake of 900,000 shares at a price of $14.47 per share. This insider confidence underscores Metagenomi's potential and serves as a bullish indicator for prospective investors. Financial Performance and Market Positioning: Despite its relatively modest market capitalization of $456.337 million, Metagenomi boasts a compelling growth trajectory. Recent financial data indicates a positive momentum, with total revenue reaching $37.952 million, signaling robust demand for the company's innovative genetic therapies. Furthermore, the company's strategic collaborations with industry giants like ModernaTX, Inc. and Ionis Pharmaceuticals, Inc. underscore its market credibility and growth potential. Gene Research Revolution: Metagenomi's strategic focus on precision genetic medicines aligns perfectly with the burgeoning gene research revolution. As the healthcare landscape increasingly gravitates towards personalized therapies and gene editing technologies, Metagenomi stands poised to capitalize on this paradigm shift. The convergence of cutting-edge science, favorable regulatory tailwinds, and heightened investor interest in genetic medicine positions Metagenomi as a prime beneficiary of the gene research boom. Investment Considerations: While Metagenomi's low share price and the red-hot gene research market present compelling investment opportunities, prudent investors must weigh certain considerations. The biotechnology sector inherently entails high risk and volatility, with clinical trial outcomes, regulatory approvals, and competitive dynamics exerting significant influence on stock performance. Additionally, Metagenomi's status as an early-stage company necessitates a long-term investment horizon and a tolerance for market fluctuations. Conclusion: In conclusion, Metagenomi, Inc. emerges as a compelling investment opportunity in the genetic medicine landscape. With a low share price, recent IPO buzz, and a strategic foothold in the gene research revolution, Metagenomi embodies the quintessential blend of innovation, potential, and market positioning. While investors must exercise due diligence and navigate the inherent risks of the biotechnology sector, Metagenomi's transformative vision and burgeoning market opportunities make it a stock worth watching and potentially adding to one's investment portfolio.
NASDAQ:AMDLong
by OnePunchSolutions
1